Enovix Corporation vs Procter & Gamble Co — how do they compare? Enovix Corporation trades at $2.45 (market cap $549.72M), while Procter & Gamble Co trades at $151.06 (market cap $349.77B). The key difference: Procter & Gamble Co is far larger — about 636.3× Enovix Corporation's market cap, and Procter & Gamble Co pays a 2.89% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Procter & Gamble Co for 131 Days on average.
| ENVX | PG | |
|---|---|---|
Market Cap | $549.72M | $349.77B |
Volume | 6,635,687 | 10,055,825 |
Sector | Industrials | Consumer Staples |
52-Week High | $13.19 | $167.18 |
52-Week Low | $2.50 | $138.10 |
Typical Hold Time | 11 Days | 131 Days |
Enterprise Value | $611.42M | $375.61B |
Dividend Yield | — | 2.89% |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.46, down 3.53% on the day, reflecting a bearish technical trend. The company is in a high-growth investment phase, with revenue growing to $36 million in 2026 but reporting significant losses. Recent news highlights a CEO transition and progress in battery manufacturing for defense and consumer electronics, while analyst consensus remains largely positive with a $10.75 price target.
The outlook is bifurcated: strong analyst buy ratings and institutional interest signal long-term potential, but high cash burn, persistent losses, and bearish technical indicators present substantial near-term risks. Investment hinges on successful commercialization and achieving profitability from current expansion efforts.
Procter & Gamble (PG) trades at $147.82, down 0.4% on the day, showing resilience amid market volatility. The stock maintains a bullish technical signal with strong moving average support and has consistently beaten earnings estimates in recent quarters. PG demonstrates robust fundamentals with $84.28B revenue, 18.44% net margin, and steady dividend payments, though valuation multiples remain elevated versus peers.
PG offers stable growth with dividend reliability but faces premium valuation concerns. The 8.3% upside to consensus target of $160.13 suggests moderate potential, while competitive pressures and soft demand outlook present headwinds. Institutional ownership trends show mixed positioning, requiring careful monitoring of margin sustainability and consumer spending patterns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →